Home/Pipeline/Semaglutide LAI, 1M

Semaglutide LAI, 1M

Type 2 Diabetes Mellitus and Obesity

Pre-clinicalActive

Key Facts

Indication
Type 2 Diabetes Mellitus and Obesity
Phase
Pre-clinical
Status
Active
Company

About Bostal Pharma

Bostal LLC is a private, technology-driven pharmaceutical company with a strategic focus on developing long-acting injectable (LAI) products using its proprietary drug delivery platforms. The company leverages a 505(b)(2) regulatory pathway to reformulate established molecules, aiming to improve dosing convenience and adherence in therapeutic areas like metabolic and neuropsychiatric disorders. With integrated R&D and GMP manufacturing capabilities, Bostal seeks global partnerships to co-develop and commercialize its pipeline candidates.

View full company profile